Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 158

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- a Systematic Review

Unaiza Faizan, MD, Muhammad Saad Farooqi, MDMBBS, Hassaan Imtiaz, MD, Muhammad Yasir Anwar, Muhammad Khawar Sana, MD, Arafat Ali Farooqui, MD, Zahoor Ahmed, MD, Abdul Jabbar Dar, MD, Hamza Hashmi, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-141078

Published: 2020

Journal Articles

Safety and Efficacy of Purine Analogs for Treatment of Waldenstrom Macroglobulinemia

Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Muhaddis Ejaz Ahmad, MD, Muhammad Ali Mirza, MD, Farhan Khalid, MBBS, Muhammad Tayyeb, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Sana Irfan Khan, MD, Richi Kashyap, MD, Saad Javed, MD, Unaiza Faizan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-138750

Published: 2020

Journal Articles

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Muhammad Ali Mirza, MD, Muhaddis Ejaz Ahmad, MD, Sobia Aamir, MDFCPS, Richi Kashyap, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Israr Khan, Arshia Akbar, MDMBBS, Waqas Khan, Muhammad Tayyeb, MD, Sundas Ali, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-138964

Published: 2020

Journal Articles

A Systematic Review on Efficacy and Safety of Bortezomib Based Regimens for Treatment of Waldensterom Macroglobulinemia

Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Muhaddis Ejaz Ahmad, MD, Muhammad Ali Mirza, MD, Farhan Khalid, MBBS, Ali Jaan, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Atif Irfan Khan, MD, Richi Kashyap, MD, Anam Khan, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138718

Published: 2020

Journal Articles

Efficacy of Selinexor Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review

Farhan Khalid, MBBS, Mydah Sajid Hashmi, MD, Muhammad Tayyeb, MD, Ali Jaan, MD, Zahoor Ahmed, MD, Abdul Jabbar Dar, MD, Sobia Aamir, MDFCPS, Qasim Khurshid, MD, Richi Kashyap, MD, Israr Khan, Saif Ur Rehman, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-139173

Published: 2020

Journal Articles

Efficacy of Venetoclax Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Laila Hashim, MBBS, Muhammad Salman Faisal, MD MBBS, Zahoor Ahmed, MD, Insija Ilyas Selene, MBBS, Moazzam Shahzad, MD, Syed Maaz Abdullah, MBBS, Yazan Samhouri, MD, Muhammad Yasir, MD, Ahsan Wahab, MD, Hamid Ehsan, MDMBBS, Karun Neupane, MBBS,MD, Faiz Anwer, MD, Salman Fazal, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-142054

Published: 2020

Journal Articles

Role of Hypomethylating Agents in Accelerated and Blast Phase of Philadelphia Negative Myeloproliferative Neoplasms: A Systematic Review

Karun Neupane, MBBS,MD, Muhammad Salman Faisal, MD MBBS, Yazan Samhouri, MD, Israr Khan, Asim Tameez Ud Din, MD MBBS, Zahoor Ahmed, MD, Muhammad Aadil Rahman, MBBS, Ali Younas Khan, MD, Hamid Ehsan, MDMBBS, Vinayak Aryal, MBBS, MD, Syed Maaz Abdullah, MBBS, Abdul Rafae, MD, Faiz Anwer, MD, Salman Fazal, MD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-138847

Published: 2020

Journal Articles

Efficacy of Ixazomib and Bortezomib with Lenalidomide Combination Regimens for Multiple Myeloma: A Systematic Review

Muhammad Khawar Sana, MD, Syed Maaz Abdullah, MBBS, Saad Javed, MD, Hamid Ehsan, MDMBBS, Unaiza Faizan, MD, Farhan Khalid, MBBS, Ali Jaan, MD, Muhammad Tayyeb, MD, Sikander Abdullah, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-142274

Published: 2020

Journal Articles

Comparing the Efficacy of Cyclophosphamide Versus Lenalidomide in Combination with Bortezomib for Newly Diagnosed Multiple Myeloma Treatment: A Systematic Review

Muhammad Khawar Sana, MD, Syed Maaz Abdullah, MBBS, Hamid Ehsan, MDMBBS, Sikander Abdullah, MBBS, Amrat Ehsan, MD, Muhammad Ans Sharif, MBBS, Sajid Ehsan, MD, Richi Kashyap, MD, Talha Badar, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 42.

https://doi.org/10.1182/blood-2020-142330

Published: 2020

Journal Articles

Novel Therapies for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: A Review of Clinical Trials

Ahmad Iftikhar, MD, Muhammad Ahmad, MBBS, Pranali Pachika, MD, Faryal Razzaq, MBBS, Muhammad Ashar Ashar Ali, Hizra Farrukh, MBBS, Azka Latif, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-142903

Published: 2020

Journal Articles

Spleen and Symptom Responses of JAK Inhibitors in Myelofibrosis; A Systematic Review of Phase 2 and 3 Trials

Muhammad Ans Sharif, MBBS, Muhammad Salman Faisal, MD MBBS, Yazan Samhouri, MD, Laila Hashim, MBBS, Muhammad Yasir, MD, Muhammad Yasir Anwar, Ali Younas Khan, MD, Moazzam Shahzad, MD, Anum Javaid, MD, Muhammad Aadil Rahman, MBBS, Faiz Anwer, MD, Salman Fazal, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-140131

Published: 2020

Journal Articles

Safety and Efficacy of Four Drug Versus Three Drug Regimens Among Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

Saad Ullah Malik, MD, Nazma Hanif, Priyanka Kumari, Khadija Noor Sami, MD, Chase Warner, Yury Kachynski, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 3.

https://doi.org/10.1182/blood-2020-143379

Published: 2020

Journal Articles

Systematic Review of Phase III Trials of Daratumumab Based Regimens in Relapsed Refractory Multiple Myeloma

Karun Neupane, MBBS,MD, Zahoor Ahmed, MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Arafat Ali Farooqui, MD, Muhammad Salman Faisal, MD MBBS, Syed Maaz Abdullah, MBBS, Richi Kashyap, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-134305

Published: 2020

Journal Articles

Safety and Efficacy of Anti-Bcma CAR-T Cells for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Literature

Israr Khan, Abdul Rafae, MD, Anum Javaid, MBBS, Zahoor Ahmed, MD, Haifza Abeera Qadeer, MBBS, Sana Irfan Khan, MD, Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Ali Jaan, MD, Farhan Khalid, MBBS, Zobia Aijaz, MBBS, Mydah Sajid Hashmi, MD, Mustafa Nadeem Malik, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-134529

Published: 2020

Journal Articles

Efficacy and Safety of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-Analysis

Sana Irfan Khan, MD, Muhammad Yasir Anwar, Abdul Rafae, MD, Anam Khan, Atif Irfan Khan, MD, Sobia Aamir, MDFCPS, Syeda Sabeeka Batool, MBBS, MD, Asim Tameez Ud Din, MD MBBS, Israr Khan, Anum Javaid, MD, Haifza Abeera Qadeer, MBBS, Zahoor Ahmed, MD, Rohail Gul, Zobia Aijaz, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-134986

Published: 2020

Journal Articles

A Systematic Review of Phase III Clinical Trials of Daratumumab Addition to Standard Care Regimen for Newly Diagnosed Multiple Myeloma

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Arafat Ali Farooqui, MD, Muhammad Salman Faisal, MD MBBS, Shaha Nabeel, MD, Abdur Rehman Jamil, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-134895

Published: 2020

Journal Articles

Efficacy and Safety of Lenalidomide Based Regimens in Diffuse Large B Cell Lymphoma: A Systematic Review and Meta-Analysis of Clinical Trials

Wajeeha Aiman, MD, Muhammad Ashar Ali, MD, Rimsha Ali, Farwah N. Fatima, MBBS, Nayab Mirza, MD, Anum Javaid, MD, Muhammad Yasir Anwar, Shammas Farooq Bajwa, Rohail Gul, Asrar Ahmad, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-136017

Published: 2020

Journal Articles

Efficacy and Safety of Isatuximab in Relapsed Refractory Multiple Myeloma: A Systematic Review

Mydah Sajid Hashmi, MD, Ali Jaan, MD, Muhammad Ans Sharif, MBBS, Summera Aziz, Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Muhammad Salman Faisal, MD MBBS, Israr Khan, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-136079

Published: 2020

Journal Articles

Risk of Serious Infections with Lenalidomide Based Regimens in Multiple Myeloma: A Network Meta-Analysis

Nayab Mirza, MD, Anum Javaid, MD, Muhammad Ashar Ali, MD, Wajeeha Aiman, MD, Muhammad Yasir Anwar, Farwah N. Fatima, MBBS, Rimsha Ali, Aqsa Mumtaz, MBBS, Sana Khan, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-136455

Published: 2020

Journal Articles

The Role of Checkpoint Inhibitors in Adults with Classical Hodgkin Lymphoma; A Systematic Review and Meta-Analysis of Phase II and III Clinical Trials

Yazan Samhouri, MD, Muhammad Yasir Anwar, Ali Younas Khan, MD, Urwat Til Vusqa, MD, Iqraa Ansar, MDMBBS, Muhammad S. Anil, MD, Lynna Alnimer, MD, Taha Sheikh, MDMPH, Muhammad Aslam Khan, MD, Faiz Anwer, MD, Salman Fazal, MD, John Lister, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-140591

Published: 2020

NARROW

Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- a Systematic Review

Safety and Efficacy of Purine Analogs for Treatment of Waldenstrom Macroglobulinemia

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

A Systematic Review on Efficacy and Safety of Bortezomib Based Regimens for Treatment of Waldensterom Macroglobulinemia

Efficacy of Selinexor Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review

Efficacy of Venetoclax Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Role of Hypomethylating Agents in Accelerated and Blast Phase of Philadelphia Negative Myeloproliferative Neoplasms: A Systematic Review

Efficacy of Ixazomib and Bortezomib with Lenalidomide Combination Regimens for Multiple Myeloma: A Systematic Review

Comparing the Efficacy of Cyclophosphamide Versus Lenalidomide in Combination with Bortezomib for Newly Diagnosed Multiple Myeloma Treatment: A Systematic Review

Novel Therapies for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: A Review of Clinical Trials

Spleen and Symptom Responses of JAK Inhibitors in Myelofibrosis; A Systematic Review of Phase 2 and 3 Trials

Safety and Efficacy of Four Drug Versus Three Drug Regimens Among Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

Systematic Review of Phase III Trials of Daratumumab Based Regimens in Relapsed Refractory Multiple Myeloma

Safety and Efficacy of Anti-Bcma CAR-T Cells for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Literature

Efficacy and Safety of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-Analysis

A Systematic Review of Phase III Clinical Trials of Daratumumab Addition to Standard Care Regimen for Newly Diagnosed Multiple Myeloma

Efficacy and Safety of Lenalidomide Based Regimens in Diffuse Large B Cell Lymphoma: A Systematic Review and Meta-Analysis of Clinical Trials

Efficacy and Safety of Isatuximab in Relapsed Refractory Multiple Myeloma: A Systematic Review

Risk of Serious Infections with Lenalidomide Based Regimens in Multiple Myeloma: A Network Meta-Analysis

The Role of Checkpoint Inhibitors in Adults with Classical Hodgkin Lymphoma; A Systematic Review and Meta-Analysis of Phase II and III Clinical Trials

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only